AI Healthcare Regulations in Pennsylvania (2024 Guide)

Pennsylvania has no single AI-in-healthcare statute as of mid-2024. Compliance stems from a patchwork of existing state health, privacy, and professional licensing laws, layered on top of federal rules from the FDA, HHS, and ONC. Clinical AI tools face the sharpest scrutiny.

Quick Answer: Is AI in Healthcare Regulated in Pennsylvania?

Yes, but not through a dedicated AI law. As of mid-2024, Pennsylvania has not enacted any statute or regulation specifically governing artificial intelligence in healthcare. Instead, compliance obligations arise from overlapping state and federal laws that can apply to AI tools depending on their use.

At the federal level, the FDA, HHS, and ONC set the primary binding rules. An AI diagnostic tool may require FDA clearance as Software as a Medical Device (SaMD). HIPAA governs how patient data flows through AI systems. The ONC Health Data, Technology, and Interoperability (HTI-1) Final Rule, published at 89 Fed. Reg. 1192 (Jan. 9, 2024), adds transparency and interoperability requirements that Pennsylvania providers must meet.

Pennsylvania layers its own breach notification statute, professional practice acts, and anti-discrimination law on top of these federal rules. The Pennsylvania Medical Practice Act (63 P.S. § 422.1 et seq.) establishes that a licensed physician cannot delegate clinical judgment to an algorithm. If an AI tool produces a wrong diagnosis and the clinician acts on it without independent verification, the clinician bears the liability.

By stakeholder:

• Developers and vendors face FDA SaMD classification, HIPAA Business Associate obligations, and Pennsylvania breach notification requirements if they hold patient data.
• Hospitals and health systems must govern AI tools through clinical credentialing processes, CMS Conditions of Participation, and Pennsylvania Department of Health facility licensure rules (28 Pa. Code).
• Individual clinicians remain personally accountable under their respective practice acts for any AI-assisted clinical decision.
• Insurers and payers face Pennsylvania Insurance Department oversight when AI drives prior authorization or claims adjudication.

Pennsylvania Statutes and Regulations That Apply to AI in Healthcare

Pennsylvania Breach of Personal Information Notification Act (73 P.S. § 2301 et seq.)

This statute requires any entity that maintains computerized data including personal information to notify affected Pennsylvania residents when a breach occurs. AI systems that ingest, process, or store patient data, including names combined with medical or financial identifiers, fall within its scope. Health AI vendors operating as third-party processors are covered. Notification must go to affected individuals and, depending on the scale of the breach, to the Pennsylvania Attorney General. Consult the Pennsylvania Office of Attorney General for current enforcement posture and notification timelines.

Pennsylvania Medical Practice Act (63 P.S. § 422.1 et seq.)

The Act is a primary source of state-level accountability for clinical AI. It governs the practice of medicine by licensed physicians and holds them responsible for clinical decisions. Using an AI tool for diagnosis, treatment planning, or clinical decision support does not transfer that responsibility. A physician who relies on an AI output without exercising independent professional judgment may face disciplinary action by the State Board of Medicine or civil liability. Consult the State Board of Medicine, under the Pennsylvania Department of State's Bureau of Professional and Occupational Affairs, for specific guidance on AI in clinical practice.

Pennsylvania Osteopathic Medical Practice Act and Pennsylvania Nursing Law (63 P.S. § 211 et seq.)

Parallel accountability rules apply to DOs, registered nurses, nurse practitioners, and certified registered nurse anesthetists. The Pennsylvania Nursing Law (63 P.S. § 211 et seq.) and the Osteopathic Medical Practice Act apply a similar principle of professional accountability. Licensees generally cannot delegate professional judgment to a software system. Nurse practitioners using AI-assisted clinical tools should document their independent clinical reasoning separately from any AI-generated recommendation.

Mental Health Procedures Act (50 P.S. § 7101 et seq.)

This Act imposes heightened confidentiality and consent requirements on AI tools used in behavioral health. Patient rights protections, consent requirements, and confidentiality rules apply to any system that processes mental health records or supports clinical decisions in psychiatric or substance-use treatment contexts. Developers building AI for behavioral health must review this statute carefully before deployment in Pennsylvania.

Pennsylvania Human Relations Act (43 P.S. § 951 et seq.)

If an AI triage, risk-scoring, or prior-authorization tool produces outputs that systematically disadvantage patients based on race, sex, national origin, disability, or other protected characteristics, that output may constitute unlawful discrimination under this Act. The Pennsylvania Human Relations Commission enforces this statute. Health systems that deploy third-party AI tools may not be insulated from liability simply because the bias originated in the vendor's model. Consult the Commission for guidance on algorithmic bias.

Pennsylvania Insurance Department and AI-Driven Prior Authorization

As of mid-2024, consult the Pennsylvania Insurance Department directly for any bulletins on algorithmic underwriting or AI-driven prior authorization practices. The Department has general authority to regulate unfair claims practices but has not issued a specific bulletin on AI-driven prior authorization confirmed in available source material. Check the Department's bulletin archive at insurance.pa.gov.

The Liability Gap: No Pennsylvania AI Liability Statute

Pennsylvania has not enacted a statute that specifically assigns liability for AI-assisted clinical errors, establishes a duty of care for AI developers toward patients, or creates a private right of action against an AI system's deployer. This gap means disputes will be resolved under existing tort law, professional licensing standards, and contract terms, creating uncertainty. Until the legislature acts, treat AI tools as extensions of the clinician's judgment, not as independent actors.

Federal Rules That Govern AI Healthcare Tools Used in Pennsylvania

FDA Software as a Medical Device (SaMD) Classification

The FDA's framework for AI/ML-based SaMD determines whether a clinical AI tool requires premarket clearance. An AI tool that analyzes medical images to detect pathology, predicts patient deterioration, or recommends a specific treatment is likely a medical device under 21 U.S.C. § 360e. Depending on risk level, it may require 510(k) clearance or De Novo authorization. The FDA's guidance on AI/ML in SaMD allows for predetermined change control plans, which let developers update AI models post-clearance within defined parameters without a new submission. Pennsylvania health systems should verify FDA clearance status before deploying clinical AI tools. Contact the FDA Digital Health Center of Excellence for classification questions.

HIPAA Privacy and Security Rules (45 C.F.R. Parts 160 and 164)

Any AI vendor that receives, processes, or stores protected health information on behalf of a covered entity is a Business Associate under HIPAA. A signed Business Associate Agreement (BAA) is mandatory before data sharing begins. The Security Rule (45 C.F.R. Part 164, Subpart C) requires technical safeguards that AI systems must meet, including access controls, audit logs, and encryption. The HHS Office for Civil Rights (OCR) enforces these rules. OCR Region III, based in Philadelphia, handles Pennsylvania complaints.

21st Century Cures Act, Information Blocking (Pub. L. 114-255, § 4004)

AI systems deployed in Pennsylvania healthcare settings must not suppress or impede the flow of electronic health information. An AI tool that filters, delays, or withholds clinical data in ways that limit interoperability may constitute information blocking under the Cures Act. ONC and the HHS Office of Inspector General share enforcement authority.

ONC HTI-1 Final Rule (89 Fed. Reg. 1192, Jan. 9, 2024)

The HTI-1 rule requires health IT developers certified under ONC's program to provide transparency about predictive decision support interventions, including AI tools. Developers must disclose the intervention's source, logic, and any known limitations. Pennsylvania providers using ONC-certified health IT must ensure their AI-integrated systems comply with these transparency provisions.

FTC Act Section 5

The Federal Trade Commission has authority to act against deceptive or unfair claims about AI accuracy, bias, or clinical performance. A vendor that overstates its AI tool's diagnostic accuracy or conceals known bias in marketing to Pennsylvania health systems faces FTC enforcement exposure.

CMS Conditions of Participation (42 C.F.R. Part 482)

Hospitals certified to participate in Medicare and Medicaid must meet CMS Conditions of Participation. While CMS has not issued AI-specific CoP rules as of mid-2024, existing requirements for quality assessment, patient rights, and medical staff governance apply to AI-assisted care. Consult CMS directly for current survey guidance on AI tool oversight.

What Changed Recently: Pennsylvania Legislative Activity and Emerging Rules

The 2019-2020 Symbolic Resolutions

Pennsylvania legislative activity on health IT includes two symbolic resolutions from the 2019-2020 session. HR 224 and SR 95 both designated April 30, 2019, as "Pennsylvania Health Care Information Technology Awareness Day." Both were adopted. Neither created any regulatory obligation, established any agency authority, or appropriated any funds.

2023-2024 General Assembly Session

As of mid-2024, no Pennsylvania AI-specific healthcare bill has been confirmed as enacted in the 2023-2024 General Assembly session. Consult the Pennsylvania General Assembly's bill search at legis.state.pa.us to verify the current status of any introduced legislation.

Pennsylvania Department of Health Executive Guidance

As of mid-2024, consult the Pennsylvania Department of Health directly to confirm whether any formal bulletin or policy statement on clinical AI has been issued. The Department's Bureau of Health Planning is the appropriate contact point.

The Colorado Comparison

Colorado enacted SB 169 in 2024, creating specific obligations for developers of high-risk AI systems, including those used in healthcare. Pennsylvania has not introduced a comparable bill. This gap means Pennsylvania providers must build their compliance frameworks around federal standards and existing state professional-practice obligations.

What to Watch

Monitor any AI-related bills introduced in the Pennsylvania General Assembly, potential rulemaking on health IT governance from the Pennsylvania Department of Health, and federal preemption questions that will arise if Pennsylvania passes AI legislation that conflicts with FDA or ONC frameworks.

Compliance Requirements by Stakeholder Type

Enforcement jurisdiction overlaps. The Pennsylvania Department of State's Bureau of Professional and Occupational Affairs (BPOA) handles clinician licensing. The Pennsylvania Department of Health handles facility licensure. Federal agencies handle HIPAA, FDA, and CMS matters. A single AI-related adverse event can trigger parallel investigations.

Liability, Malpractice, and Ethical Considerations for AI in Pennsylvania Healthcare

The Standard of Care Does Not Shift

Pennsylvania medical malpractice law applies the reasonable physician standard. Using an AI tool does not transfer liability to the software developer when a clinician acts on a flawed output. If a physician accepts an AI-generated diagnosis without independent clinical evaluation and the patient is harmed, the physician is exposed. This interpretation is consistent with the Medical Practice Act (63 P.S. § 422.1 et seq.) and general Pennsylvania tort principles.

Pennsylvania MCARE Act (40 P.S. § 1303.101 et seq.)

The Medical Care Availability and Reduction of Error Act governs medical malpractice claims and adverse event reporting. It applies to AI-related adverse events the same way it applies to any clinical error. There is no AI-specific safe harbor. As of mid-2024, no Pennsylvania court has issued a published decision interpreting the MCARE Act in the context of AI-assisted clinical errors. Consult Pennsylvania healthcare counsel for current case law developments.

Informed Consent

Pennsylvania informed consent law requires disclosure of material risks of a proposed treatment. Whether a clinician must disclose that an AI tool was used in diagnosis or treatment is an open legal question in Pennsylvania as of mid-2024. The prudent approach is to document AI tool use in the medical record and, where the AI output materially influenced a decision, to discuss it with the patient.

Vendor Contracts and Indemnification

Health systems should negotiate AI procurement contracts to include clear indemnification provisions covering claims arising from model errors or bias. Representations and warranties about FDA clearance status, training data quality, and known limitations should be in writing. A vendor that misrepresents its FDA clearance status creates both contractual and FTC exposure.

Algorithmic Bias and the Pennsylvania Human Relations Act (43 P.S. § 951 et seq.)

If a deployed AI tool produces outputs that systematically disadvantage patients in a protected class, the health system deploying that tool, not just the developer, may face a complaint before the Pennsylvania Human Relations Commission. Conducting a bias audit before and during deployment is a key risk-management measure.

Peer Review Privilege (63 P.S. § 425.4)

Pennsylvania's Peer Review Protection Act shields certain peer review proceedings from discovery in civil litigation. Whether internal AI performance audits or AI governance committee minutes qualify for this protection is unsettled. The privilege applies to "professional health care providers" reviewing "professional conduct." Courts have not addressed whether AI audit processes fit that definition. Consult Pennsylvania healthcare counsel before assuming peer review privilege covers AI governance records.

Malpractice Insurance

As of mid-2024, consult the Pennsylvania Insurance Department and your malpractice carrier to confirm whether your policy covers claims arising from AI-assisted care. Some carriers have begun adding AI-related exclusions or endorsements.

Next Steps and Who to Contact in Pennsylvania

Five-Step Compliance Checklist

1. Inventory all AI tools. Catalog every AI system in use. Classify each as SaMD (clinical decision support, diagnostics), administrative AI (billing, coding), or operational AI (staffing).
2. Confirm FDA clearance status. For any SaMD tool, verify that the vendor holds current FDA 510(k) clearance or De Novo authorization. Request written documentation.
3. Review and update Business Associate Agreements. Every AI vendor that touches protected health information must have a signed, current BAA. Review agreements for AI-specific risks like model training on patient data and breach notification timelines.
4. Audit data flows under the PA Breach Notification Act and HIPAA Security Rule. Map how patient data moves through each AI system. Confirm encryption, access controls, and audit logging meet HIPAA Security Rule requirements (45 C.F.R. Part 164, Subpart C) and that breach notification procedures are in place under 73 P.S. § 2301 et seq.
5. Consult your Pennsylvania licensing board on documentation standards. Contact the relevant board through BPOA to ask for guidance on documenting AI use. Document AI tool use in clinical records now.

Official Contacts

Pennsylvania Department of Health, Bureau of Health Planning Website: health.pa.gov Phone: (717) 787-6436 Use for: facility licensure, DOH guidance on clinical AI, health IT policy.

Pennsylvania Department of State, Bureau of Professional and Occupational Affairs (BPOA) Website: dos.pa.gov/ProfessionalLicensing Phone: (717) 787-8503 Use for: clinician licensing, board-specific AI practice standards, disciplinary process.

Pennsylvania Insurance Department Website: insurance.pa.gov Phone: (717) 787-2317 Use for: payer AI prior authorization, malpractice coverage, insurer bulletins.

HHS Office for Civil Rights, Region III (Philadelphia) 150 S. Independence Mall West, Suite 372, Philadelphia, PA 19106 Phone: (215) 861-4441 Use for: HIPAA complaints involving AI, OCR audit inquiries, BAA enforcement.

FDA Digital Health